Literature DB >> 458249

Predisposing factors to thrombosis in systemic lupus erythematosus: possible relation to endothelial cell damage.

E Angles-Cano, Y Sultan, J P Clauvel.   

Abstract

We studied 28 patients with SLE, five of whom had had thrombotic episodes. Platelet function and coagulation and fibrinolytic studies were performed to determine whether any of these factors may predispose to thrombosis in SLE. An inhibitor of blood coagulation was detected in 12 patients, and von Willebrand's syndrome was observed in two others. The most striking findings which could be correlated with thromboembolic phenomena were the increase in VII R:WF and the absence of plasminogen activator release after venous occlusion. Both proteins are synthesized by the endothelial cell, and the abnormalities observed are possibly related to damage of the vascular endothelium by immune complexes observed in SLE.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 458249

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  36 in total

Review 1.  Diagnosis and management of inherited and acquired thrombophilias.

Authors:  F A Spencer; R C Becker
Journal:  J Thromb Thrombolysis       Date:  1999-04       Impact factor: 2.300

2.  Plasminogen activator inhibitor and von Willebrand factor in polymyalgia rheumatica.

Authors:  A Uddhammar; S Rantapåå-Dahlqvist; T K Nilsson
Journal:  Clin Rheumatol       Date:  1992-06       Impact factor: 2.980

3.  Superior mesenteric artery thrombosis associated with antiphospholipid syndrome.

Authors:  M E Hamilton
Journal:  West J Med       Date:  1991-08

4.  IgG and IgM anti-endothelial cell antibodies in patients with collagen-vascular disorders.

Authors:  N P Quadros; P J Roberts-Thomson; A S Gallus
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

5.  Methods for detecting lupus anticoagulants and their relation to thrombosis and miscarriage in patients with systemic lupus erythematosus.

Authors:  D Ferro; M Saliola; C Quintarelli; G Valesini; S Basili; A M Grandilli; M S Bonavita; F Violi
Journal:  J Clin Pathol       Date:  1992-04       Impact factor: 3.411

6.  Disseminated intravascular coagulation with renal and liver damage as the predominant manifestations of recurrent relapses in systemic juvenile rheumatoid arthritis.

Authors:  D Schwartz; M Averbuch; A Pines; R Kornovsky; Y Levo
Journal:  Ann Rheum Dis       Date:  1992-03       Impact factor: 19.103

Review 7.  The antiphospholipid antibody dilemma.

Authors:  R H Derksen; P Hasselaar; J D Oosting; P G De Groot
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

8.  Fetal loss treatment in patients with antiphospholipid antibodies.

Authors:  J Ordi; J Barquinero; M Vilardell; R Jordana; C Tolosa; A Selva; E Genover
Journal:  Ann Rheum Dis       Date:  1989-10       Impact factor: 19.103

Review 9.  Gastrointestinal hemorrhage and intestinal ischemia associated with anticardiolipin antibodies.

Authors:  M S Cappell; N Mikhail; N Gujral
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

10.  Relation between antithrombin III and clinical and serological parameters in systemic lupus erythematosus.

Authors:  M P Jarrett; D Green; C H Ts'ao
Journal:  J Clin Pathol       Date:  1983-03       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.